Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chuanzhitongluojiaonang for acute ischemic stroke
ChiCTR2200057042Phase 4Not yet recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of chuanzhitongluojiaonang in ischemic stroke (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: NIHSS score change value. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
chuanzhitongluojiaonang
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200057042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057042.